Arrowhead Research reported $-173085000 in Stock for its fiscal quarter ending in December of 2024.


Stock Change Date
Agios Pharmaceuticals USD 30.85M 1.24M Jun/2025
Alnylam Pharmaceuticals USD 71.69M 6.11M Jun/2025
Arrowhead Research USD -173085000 173.08M Dec/2024
Incyte USD 83.42M 19.45M Jun/2025
Ionis Pharmaceuticals USD 8.48M 3.02M Jun/2025
Ligand Pharmaceuticals USD 15.49M 875K Jun/2025
Merck USD 6.6B 405M Jun/2025
Moderna USD 240M 112M Jun/2025
Novartis USD 6.31B 478M Jun/2025
Sarepta Therapeutics USD 994.04M 52.6M Jun/2025
TG Therapeutics 155.2M 2.56M Jun/2025
Ultragenyx Pharmaceutical USD 46.5M 467K Jun/2025
Vertex Pharmaceuticals USD 1.5B 139.6M Jun/2025
Xencor USD 0 0 Jun/2020